头颈癌根治性放疗延长的生存影响与易感因素
基于美国国家癌症数据库2004-2015年36,367例接受根治性放疗的非转移性鼻咽、口咽、喉或下咽癌成人患者,分析放疗延长对生存的影响及预测因素。结果显示放疗每延长1天死亡相对风险增加2%,延长超过8天者4年总生存绝对下降12%,而延长1-3天无显著不良影响。全身治疗、基线合并症、缺乏私人保险和肿瘤/淋巴结分期是延长的主要预测因素,高设施年治疗量则显著保护。
要点
- 放疗每延长1天,死亡相对风险增加2%(P<.0001)。
- 延长超过8天者4年总生存绝对下降12%,延长4-8天下降4%。
- 延长1-3天未显示显著不良生存影响。
核心结论
- 根治性头颈癌放疗延长尤其超过8天具有显著不利生存影响。
- 全身治疗和设施年治疗量是放疗延长的主要预测因素。
研究设计与样本
- 回顾性队列研究,查询美国国家癌症数据库2004-2015年数据。
- 纳入36,367例接受根治性放疗(66-70 Gy/30-35次,每次2-2.2 Gy)的非转移性鼻咽、口咽、喉或下咽癌成人患者。
- 采用多因素Cox回归和倾向性评分匹配分析放疗延长对生存的影响,多因素多项逻辑回归识别延长预测因素。
主要发现
- 放疗延长作为连续变量,每延长1天死亡相对风险增加2%(P<.0001)。
- 匹配队列中,延长4-8天和超过8天者4年总生存绝对下降分别为4%和12%(P<.0001)。
- 延长1-3天未显示显著不良影响。
- 延长风险增加的预测因素包括全身治疗、基线合并症、缺乏私人保险和肿瘤/淋巴结分期。
- 设施年治疗量最高四分位(>11.5例/年)者长时间延长风险降低55%。
临床怎么用
- 应早期识别放疗中断高风险患者并实施预防措施。
- 对接受全身治疗、有合并症、缺乏私人保险或晚期分期的患者尤其关注放疗延长风险。
- 高年治疗量设施与较低长时间延长风险相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: To quantify the survival impact of prolongation of definitive radiotherapy (RT) for head and neck cancer in a national, modern cohort, and to identify predictive factors for prolongation. MATERIALS AND METHODS: The National Cancer Database was queried for adults with non-metastatic cancer of the nasopharynx, oropharynx, larynx, or hypopharynx diagnosed 2004-2015, treated with definitive RT to 66-70 Gy in 30-35 fractions at 2-2.2 Gy per fraction. Multivariable Cox regression and propensity score matching were used to model the survival impact of RT prolongation, adjusting for potential confounders such as age and comorbidity. Predictors of RT prolongation were identified using multivariable multinomial logistic regression. RESULTS: In total, 36,367 patients were identified. As a continuous variable, RT prolongation increased the relative hazard of death by 2% per day (P < .0001). In the matched cohorts, patients with short (4-8 days) or long prolongation (>8 days) had lower absolute 4-year overall survival by 4% and 12%, respectively (P < .0001), while prolongation of 1-3 days was not significantly adverse. Major predictors of increased risk of prolongation were administration of systemic therapy, baseline comorbidity, lack of private insurance, and tumor/nodal stage. Conversely, higher facility volume was significantly protective, with a 55% lower risk of long prolongation within the topmost quartile (>11.5 patients/year). CONCLUSION: RT prolongation, especially >8 days, is significantly deleterious. Systemic therapy and facility volume were major predictors. Early identification of patients at increased risk of treatment interruptions may facilitate implementation of preventive measures.
引用
- Xiang M, Gensheimer MF, Pollom EL, et al. Prolongation of definitive head and neck cancer radiotherapy: Survival impact and predisposing factors. Radiother Oncol. 2020. PMID: 33383061. doi:10.1016/j.radonc.2020.12.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。